Jul 30, 2026 02:37AM
May 13, 2026 05:46AM
May 13, 2026 02:38AM
Jan 29, 2026 01:37AM
Jan 15, 2026 07:52AM
Nov 5, 2025 08:03AM
Oct 30, 2025 04:11AM Takeda Pharmaceutical Company Limited (TAK) Reports Q3 EPS of JPY279.00
Oct 30, 2025 03:04AM
Jul 30, 2025 05:14PM
Jul 30, 2025 02:41AM
May 8, 2025 02:36AM
Apr 2, 2025 04:50AM
Mar 3, 2025 06:46AM
Mar 3, 2025 06:45AM Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Jan 30, 2025 01:35AM
Nov 7, 2024 07:00AM
Oct 31, 2024 02:05AM
Aug 6, 2024 04:01PM
Jul 31, 2024 02:06AM
Jun 1, 2024 08:00AM
May 9, 2024 04:10AM Takeda Pharmaceutical Company Limited (TAK) Reports FY EPS of JPY484.00
May 9, 2024 02:07AM
Feb 1, 2024 01:02AM
Dec 21, 2023 07:35AM
Oct 26, 2023 02:00AM
Oct 17, 2023 07:31PM
Oct 17, 2023 07:31PM
Oct 17, 2023 07:30PM Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
Oct 17, 2023 07:30PM
Aug 7, 2023 04:01PM
Jul 27, 2023 02:00AM
May 11, 2023 02:40AM
May 2, 2023 04:01PM
Feb 2, 2023 05:40AM
Feb 2, 2023 01:00AM Takeda Reinforces Long-term Growth Through Pipeline Advancement and Two Targeted Acquisitions; Delivers Another Strong Quarter in FY2022 Q3
Dec 13, 2022 07:00AM
Oct 27, 2022 02:00AM
Aug 11, 2022 10:01AM
Jul 28, 2022 02:00AM
May 11, 2022 02:15AM
Apr 19, 2022 05:55AM
Apr 18, 2022 10:33PM Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Feb 3, 2022 05:42AM
Feb 3, 2022 01:13AM
Nov 17, 2021 08:33AM
Oct 28, 2021 02:15AM
Aug 1, 2021 07:30PM
Jul 30, 2021 02:00AM
May 11, 2021 02:35AM Takeda Delivers Resilient FY2020 Results With Strong Margins & Robust Cashflow; Underlying Revenue Growth Expected to Accelerate in FY2021
Apr 14, 2021 06:30AM

1,211,534 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All